Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (23190)
All Articles published online
|
Apr 26, 2010 (publication date) through Jan 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Affuso F, Mercurio V, Fazio V, Fazio S. Cardiovascular and metabolic effects of Berberine. World J Cardiol 2010; 2(4): 71-77 [PMID: 21160701 DOI: 10.4330/wjc.v2.i4.71] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v2/i4/71.htm |
| Number | Citing Articles |
| 1 |
Junli Zhao, Yaqian Wang, Jie Gao, Yang Jing, Wenkuan Xin. Berberine Mediated Positive Inotropic Effects on Rat Hearts via a Ca2+-Dependent Mechanism. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00821
|
| 2 |
Hongjun Li, Chengyan He, Jingying Wang, Xiaoou Li, Zhaowei Yang, Xiaoying Sun, Ling Fang, Ning Liu. Berberine activates peroxisome proliferator‐activated receptor gamma to increase atherosclerotic plaque stability in Apoe−/− mice with hyperhomocysteinemia. Journal of Diabetes Investigation 2016; 7(6): 824 doi: 10.1111/jdi.12516
|
| 3 |
Paolo Bellavite, Serafino Fazio, Flora Affuso. A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention. Molecules 2023; 28(11): 4491 doi: 10.3390/molecules28114491
|
| 4 |
Current knowledge and pharmacological profile of berberine: An update. European Journal of Pharmacology 2015; 761: 288 doi: 10.1016/j.ejphar.2015.05.068
|
| 5 |
Yanyan Wang, Yun-Ling Tai, Derrick Zhao, Yuan Zhang, Junkai Yan, Genta Kakiyama, Xuan Wang, Emily C. Gurley, Jinze Liu, Jinpeng Liu, Jimin Liu, Guanhua Lai, Phillip B. Hylemon, William M. Pandak, Weidong Chen, Huiping Zhou. Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways. Cells 2021; 10(2): 210 doi: 10.3390/cells10020210
|
| 6 |
Duo Zhi, Pan-Feng Feng, Jia-Liang Sun, Fengfeng Guo, Rui Zhang, Xin Zhao, Bao-Xin Li. The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides. European Journal of Pharmaceutical Sciences 2015; 76: 149 doi: 10.1016/j.ejps.2015.05.009
|
| 7 |
Tianzhu Zhang, Shihai Yang, Juan Du, Shao-Hsuan Kao. Protective Effects of Berberine on Isoproterenol‐Induced Acute Myocardial Ischemia in Rats through Regulating HMGB1‐TLR4 Axis. Evidence-Based Complementary and Alternative Medicine 2014; 2014(1) doi: 10.1155/2014/849783
|
| 8 |
Jian-Ta Wang, Jin-Gang Peng, Ji-Quan Zhang, Zhong-Xiao Wang, Yi Zhang, Xun-Rong Zhou, Jing Miao, Lei Tang. Novel berberine-based derivatives with potent hypoglycemic activity. Bioorganic & Medicinal Chemistry Letters 2019; 29(23): 126709 doi: 10.1016/j.bmcl.2019.126709
|
| 9 |
Y-H. Wu, S-Y Chuang, W-C. Hong, Y-J. Lai, G-J. Chang, J-H.S. Pang. Berberine Reduces Leukocyte Adhesion to Lps-Stimulated Endothelial Cells and Vcam-1 Expression Both In Vivo and In Vitro. International Journal of Immunopathology and Pharmacology 2012; 25(3): 741 doi: 10.1177/039463201202500320
|
| 10 |
Ahmad Nazari, Zahra Rostami Ghotbabadi, Kimia Sadat Kazemi, Yalda Metghalchi, Reza Tavakoli, Razieh Ziaei Rahimabadi, Mohammad Ghaheri. The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-analysis of Randomized Controlled Trials. Clinical Therapeutics 2024; 46(2): e64 doi: 10.1016/j.clinthera.2023.10.019
|
| 11 |
Serafino Fazio, Valentina Mercurio, Loredana Tibullo, Valeria Fazio, Flora Affuso. Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated. Frontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1380506
|
| 12 |
Kyungho Kim, Kwang-Il Park. A Review of Antiplatelet Activity of Traditional Medicinal Herbs on Integrative Medicine Studies. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/7125162
|
| 13 |
Maura Calvani, Angela Subbiani, Gennaro Bruno, Claudio Favre. Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/7534693
|
| 14 |
Mo-Li Zhu, Ya-Ling Yin, Song Ping, Hai-Ya Yu, Guang-Rui Wan, Xu Jian, Peng Li. Berberine promotes ischemia-induced angiogenesis in mice heart via upregulation of microRNA-29b. Clinical and Experimental Hypertension 2017; 39(7): 672 doi: 10.1080/10641963.2017.1313853
|
| 15 |
Juan Hou, Adil Manzoor Bhat, Shaban Ahmad, Khalid Raza, Sahar Qazi. In silico Analysis of ACE2 Receptor to Find Potential Herbal Drugs in COVID-19 Associated Neurological Dysfunctions. Natural Product Communications 2022; 17(8) doi: 10.1177/1934578X221118549
|
| 16 |
Meng Li, Xiangbing Shu, Hanchen Xu, Chunlei Zhang, Lili Yang, Li Zhang, Guang Ji. Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0987-5
|
| 17 |
Viriyanata Wijaya, Ondřej Janďourek, Jana Křoustková, Kateřina Hradiská-Breiterová, Jan Korábečný, Kateřina Sobolová, Eliška Kohelová, Anna Hošťálková, Klára Konečná, Marcela Šafratová, Rudolf Vrabec, Jiří Kuneš, Lubomír Opletal, Jakub Chlebek, Lucie Cahlíková. Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents. Biomolecules 2022; 12(6): 844 doi: 10.3390/biom12060844
|
| 18 |
|
| 19 |
Seyed Sajad Ahmadi, Omid Bagherzadeh, Meysam Sargazi, Farnaz Kalantar, Mohammad Amin Elahi Najafi, Mohammad Mahdi Vahedi, Amir R. Afshari, Amirhossein Sahebkar. Harnessing the therapeutic potential of phytochemicals in neuroblastoma. BioFactors 2025; 51(1) doi: 10.1002/biof.2115
|
| 20 |
|
| 21 |
Kiran Reddi, Hanxuan Li, Wei Li, Sarada Tetali. Berberine, A Phytoalkaloid, Inhibits Inflammatory Response Induced by LPS through NF-Kappaβ Pathway: Possible Involvement of the IKKα. Molecules 2021; 26(16): 4733 doi: 10.3390/molecules26164733
|
| 22 |
Chin Piow Wong, Toshio Kaneda, Hiroshi Morita. Plant natural products as an anti-lipid droplets accumulation agent. Journal of Natural Medicines 2014; 68(2): 253 doi: 10.1007/s11418-014-0822-3
|
| 23 |
Masaaki Kawano, Rie Takagi, Atsushi Kaneko, Sho Matsushita. Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses. Journal of Neuroimmunology 2015; 289: 43 doi: 10.1016/j.jneuroim.2015.10.001
|
| 24 |
Qingyun Sun, Rongmei Shan, Tianmeng Qi, Ping Yang. Berberine Reverses the Tumorigenic Function of Colon Cancer Cell-Derived Exosomes. The Tohoku Journal of Experimental Medicine 2023; 260(1): 75 doi: 10.1620/tjem.2022.J119
|
| 25 |
Fei Cheng, Yan Wang, Jing Li, Chen Su, Fang Wu, Wen-Hao Xia, Zhen Yang, Bing-Bo Yu, Yan-Xia Qiu, Jun Tao. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. International Journal of Cardiology 2013; 167(3): 936 doi: 10.1016/j.ijcard.2012.03.090
|
| 26 |
Sara S. Al Disi, M. Akhtar Anwar, Ali H. Eid. Anti-hypertensive Herbs and their Mechanisms of Action: Part I. Frontiers in Pharmacology 2016; 6 doi: 10.3389/fphar.2015.00323
|
| 27 |
Sen Yin, Wenwu Bai, Peng Li, Xu Jian, Tichao Shan, Zhenyu Tang, Xuejiao Jing, Song Ping, Quanzhong Li, Zhang Miao, Shuangxi Wang, Wensheng Ou, Jianchun Fei, Tao Guo. Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats. Clinical and Experimental Hypertension 2019; 41(8): 708 doi: 10.1080/10641963.2018.1545846
|
| 28 |
Hamed Mortazavi, Banafsheh Nikfar, Seyed-Alireza Esmaeili, Fatemeh Rafieenia, Ehsan Saburi, Shahla Chaichian, Mohammad Ali Heidari Gorji, Amir Abbas Momtazi-Borojeni. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance. European Journal of Medicinal Chemistry 2020; 187: 111951 doi: 10.1016/j.ejmech.2019.111951
|
| 29 |
Gaurav Kumar, Sanjay Kumar Dey, Suman Kundu. Herbs and their bioactive ingredients in cardio-protection: Underlying molecular mechanisms and evidences from clinical studies. Phytomedicine 2021; 92: 153753 doi: 10.1016/j.phymed.2021.153753
|
| 30 |
Hong-Bo Xiao, Zhi-Liang Sun, Heng-Bo Zhang, Da-Sheng Zhang. Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation. Pharmacological Reports 2012; 64(4): 889 doi: 10.1016/S1734-1140(12)70883-6
|
| 31 |
WEI LU, SHANSHAN DU, JIAQIANG WANG. Berberine inhibits the proliferation of prostate cancer cells and induces G0/G1 or G2/M phase arrest at different concentrations. Molecular Medicine Reports 2015; 11(5): 3920 doi: 10.3892/mmr.2014.3139
|
| 32 |
Giuseppe Marazzi, Francesco Pelliccia, Giuseppe Campolongo, Silvia Quattrino, Luca Cacciotti, Maurizio Volterrani, Carlo Gaudio, Giuseppe Rosano. Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease. The American Journal of Cardiology 2015; 116(12): 1798 doi: 10.1016/j.amjcard.2015.09.023
|
| 33 |
Bożena Sosnowska, Mohsen Mazidi, Peter Penson, Anna Gluba-Brzózka, Jacek Rysz, Maciej Banach. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis. Atherosclerosis 2017; 265: 275 doi: 10.1016/j.atherosclerosis.2017.08.027
|
| 34 |
Caitlin Lynch, Jinghua Zhao, Srilatha Sakamuru, Li Zhang, Ruili Huang, Kristine L. Witt, B. Alex Merrick, Christina T. Teng, Menghang Xia. Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays. Molecules 2019; 24(5): 841 doi: 10.3390/molecules24050841
|
| 35 |
Wenguang Chang, Li Chen, Grant M. Hatch. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. Biochemistry and Cell Biology 2015; 93(5): 479 doi: 10.1139/bcb-2014-0107
|
| 36 |
Steven G. Chrysant, George S. Chrysant. Herbs Used for the Treatment of Hypertension and their Mechanism of Action. Current Hypertension Reports 2017; 19(9) doi: 10.1007/s11906-017-0775-5
|
| 37 |
Hui-Hui Guo, Chen-Lin Feng, Wen-Xuan Zhang, Zhi-Gang Luo, Hong-Juan Zhang, Ting-Ting Zhang, Chen Ma, Yun Zhan, Rui Li, Song Wu, Zeper Abliz, Cong Li, Xiao-Lin Li, Xiao-Lei Ma, Lu-Lu Wang, Wen-Sheng Zheng, Yan-Xing Han, Jian-Dong Jiang. Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-09852-0
|
| 38 |
Ajay Srivastava, Anita Sinha, Rajiv Lall, Ramesh C. Gupta. Nutraceuticals in Veterinary Medicine. 2019; : 71 doi: 10.1007/978-3-030-04624-8_5
|
| 39 |
Yi-jia Shao, Jun Tao, Bing-bo Yu, Dan Meng, Xu-long Yang, Jia-pan Sun, Yan-xia Qiu, Xiao-yu Zhang. Berberine-Promoted CXCR4 Expression Accelerates Endothelial Repair Capacity of Early Endothelial Progenitor Cells in Persons with Prehypertension. Chinese Journal of Integrative Medicine 2018; 24(12): 897 doi: 10.1007/s11655-018-2568-3
|
| 40 |
Parameswara Rao Vuddanda, Vijayakumar Mahalingam Rajamanickam, Madhu Yaspal, Sanjay Singh. Investigations on Agglomeration and Haemocompatibility of Vitamin E TPGS Surface Modified Berberine Chloride Nanoparticles. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/951942
|
| 41 |
Min Xiao, Li Na Men, Ming Guo Xu, Guo Bing Wang, Hai Tao Lv, Cong Liu. Berberine protects endothelial progenitor cell from damage of TNF-α via the PI3K/AKT/eNOS signaling pathway. European Journal of Pharmacology 2014; 743: 11 doi: 10.1016/j.ejphar.2014.09.024
|
| 42 |
Tarawanti Verma, Manish Sinha, Nitin Bansal, Shyam Raj Yadav, Kamal Shah, Nagendra Singh Chauhan. Plants Used as Antihypertensive. Natural Products and Bioprospecting 2021; 11(2): 155 doi: 10.1007/s13659-020-00281-x
|
| 43 |
Arrigo F. G. Cicero, Alessandro Colletti. An update on the safety of nutraceuticals and effects on lipid parameters. Expert Opinion on Drug Safety 2018; 17(3): 303 doi: 10.1080/14740338.2018.1429404
|
| 44 |
Md Habban Akhter, Lamya Ahmad Al-Keridis, Mohd Saeed, Habibullah Khalilullah, Safia Obaidur Rab, Adel M. Aljadaan, Mohammad Akhlaquer Rahman, Mariusz Jaremko, Abdul-Hamid Emwas, Sarfaraz Ahmad, Nawazish Alam, Md Sajid Ali, Gyas Khan, Obaid Afzal. Enhanced drug delivery and wound healing potential of berberine-loaded chitosan–alginate nanocomposite gel: characterization and in vivo assessment. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1238961
|
| 45 |
Amirhossein Sahebkar, Maria-Corina Serban, Anna Gluba-Brzózka, Dimitri P. Mikhailidis, Arrigo F. Cicero, Jacek Rysz, Maciej Banach. Lipid-modifying effects of nutraceuticals: An evidence-based approach. Nutrition 2016; 32(11-12): 1179 doi: 10.1016/j.nut.2016.04.007
|
| 46 |
Cristina Carresi, Micaela Gliozzi, Vincenzo Musolino, Miriam Scicchitano, Federica Scarano, Francesca Bosco, Saverio Nucera, Jessica Maiuolo, Roberta Macrì, Stefano Ruga, Francesca Oppedisano, Maria Caterina Zito, Lorenza Guarnieri, Rocco Mollace, Annamaria Tavernese, Ernesto Palma, Ezio Bombardelli, Massimo Fini, Vincenzo Mollace. The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction. Nutrients 2020; 12(5): 1504 doi: 10.3390/nu12051504
|
| 47 |
Jie Song, Bing Yang, Xiaobin Jia, Mingyu Li, Wei Tan, Shitang Ma, Xinhong Shi, Liang Feng. Distinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00724
|
| 48 |
Junfang Zhang, Hailong Cao, Bing Zhang, Hanwei Cao, Xiuqin Xu, Hang Ruan, Tingting Yi, Li Tan, Rui Qu, Gang Song, Bangmao Wang, Tianhui Hu. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. Journal of Cellular and Molecular Medicine 2013; 17(11): 1484 doi: 10.1111/jcmm.12119
|
| 49 |
Weibin Zha. Transporter-mediated natural product–drug interactions for the treatment of cardiovascular diseases. Journal of Food and Drug Analysis 2018; 26(2): S32 doi: 10.1016/j.jfda.2017.11.008
|
| 50 |
Arrigo FG Cicero, Alienor Ferroni, Sibel Ertek. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. Expert Opinion on Drug Safety 2012; 11(5): 753 doi: 10.1517/14740338.2012.705827
|
| 51 |
Yanyan Wang, Xiqiao Zhou, Derrick Zhao, Xuan Wang, Emily C. Gurley, Runping Liu, Xiaojiaoyang Li, Phillip B. Hylemon, Weidong Chen, Huiping Zhou, Gianfranco D. Alpini. Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes. PLOS ONE 2020; 15(5): e0232630 doi: 10.1371/journal.pone.0232630
|
| 52 |
Lubi Lei, Jingkuo Li, Bin Wang. Efficacy and Safety Profile of Berberine Treatment in Improving Risk Factors for Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized, Double-blind Trials. Cardiology Discovery 2023; 3(2): 112 doi: 10.1097/CD9.0000000000000087
|
| 53 |
Juan Zheng, Shih-Lung Woo, Xiang Hu, Rachel Botchlett, Lulu Chen, Yuqing Huo, Chaodong Wu. Metformin and metabolic diseases: a focus on hepatic aspects. Frontiers of Medicine 2015; 9(2): 173 doi: 10.1007/s11684-015-0384-0
|
| 54 |
Xianzhi Liu, Lifu Wang, Siwei Tan, Zebin Chen, Bin Wu, Xiaoying Wu. Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.814871
|
| 55 |
Vida V Ruiz-Herrera, Shaúl A Navarro-Lara, Jaime F Andrade-Villanueva, Monserrat Alvarez-Zavala, Karina Sánchez-Reyes, Marcela Toscano-Piña, Anibal S Méndez-Clemente, Pedro Martínez-Ayala, Adriana Valle-Rodríguez, Luz A González-Hernández. Pilot study on the efficacy and safety of berberine in people with metabolic syndrome and human immunodeficiency virus infection. International Journal of STD & AIDS 2023; 34(14): 1042 doi: 10.1177/09564624231196600
|
| 56 |
Leyuan Li, Lu Chang, Xu Zhang, Zhibin Ning, Janice Mayne, Yang Ye, Alain Stintzi, Jia Liu, Daniel Figeys. Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes. Gut Microbes 2020; 11(5): 1348 doi: 10.1080/19490976.2020.1755413
|
| 57 |
Yueshan Hu, Erik A. Ehli, Julie Kittelsrud, Patrick J. Ronan, Karen Munger, Terry Downey, Krista Bohlen, Leah Callahan, Vicki Munson, Mike Jahnke, Lindsey L. Marshall, Kelly Nelson, Patricia Huizenga, Ryan Hansen, Timothy J. Soundy, Gareth E. Davies. Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine 2012; 19(10): 861 doi: 10.1016/j.phymed.2012.05.009
|
| 58 |
Seyed Hasan Ayati, Badrieh Fazeli, Amir Abbas Momtazi-borojeni, Arrigo F.G. Cicero, Matteo Pirro, Amirhossein Sahebkar. Regulatory effects of berberine on microRNome in Cancer and other conditions. Critical Reviews in Oncology/Hematology 2017; 116: 147 doi: 10.1016/j.critrevonc.2017.05.008
|
| 59 |
Parameswara Rao Vuddanda, Amit Mishra, Sanjay Kumar Singh, Sanjay Singh. Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design. Pharmaceutical Development and Technology 2015; 20(5): 579 doi: 10.3109/10837450.2014.908302
|
| 60 |
Katerina Babkova, Jan Korabecny, Ondrej Soukup, Eugenie Nepovimova, Daniel Jun, Kamil Kuca. Prolyl Oligopeptidase and Its Role in the Organism: Attention to the Most Promising and Clinically Relevant Inhibitors. Future Medicinal Chemistry 2017; 9(10): 1015 doi: 10.4155/fmc-2017-0030
|
| 61 |
Anna Bartáková, Marie Nováková. Secondary Metabolites of Plants as Modulators of Endothelium Functions. International Journal of Molecular Sciences 2021; 22(5): 2533 doi: 10.3390/ijms22052533
|
| 62 |
X Zhao, J Zhang, N Tong, X Liao, E Wang, Z Li, Y Luo, H Zuo. Berberine Attenuates Doxorubicin-Induced Cardiotoxicity in Mice. Journal of International Medical Research 2011; 39(5): 1720 doi: 10.1177/147323001103900514
|
| 63 |
Walaa M. Elwan, Amira A. Kassab, Marwa A.A. Ibrahim. The possible role of berberine in ameliorating doxorubicin- induced cardiomyopathy in adult male albino rat. The Egyptian Journal of Histology 2016; 39(3): 228 doi: 10.1097/01.EHX.0000490001.63817.c1
|
| 64 |
Yin Wang, Pengfei Du, Donghui Jiang. Berberine functions as a negative regulator in lipopolysaccharide -induced sepsis by suppressing NF-κB and IL-6 mediated STAT3 activation. Pathogens and Disease 2020; 78(7) doi: 10.1093/femspd/ftaa047
|
| 65 |
Fateme Askarifar, Ebrahim Shafaei, Mahsa Sedighi, Amir Tavakoli kareshk. Green Synthesis of Silver Nanoparticles by Hypericum perforatum extract and Berberine and Evaluation of Their Antibacterial Effects(Original Article). Journal of Ardabil University of Medical Sciences 2023; 23(3): 262 doi: 10.61186/jarums.23.3.262
|
| 66 |
Berberine inhibits low shear stress-induced glycocalyx degradation via modulating AMPK and p47phox/Hyal2 signal pathway. European Journal of Pharmacology 2019; 856: 172413 doi: 10.1016/j.ejphar.2019.172413
|
| 67 |
Miao Xu, Yuanyuan Xiao, Jun Yin, Wolin Hou, Xueying Yu, Li Shen, Fang Liu, Li Wei, Weiping Jia, Hossein Ardehali. Berberine Promotes Glucose Consumption Independently of AMP-Activated Protein Kinase Activation. PLoS ONE 2014; 9(7): e103702 doi: 10.1371/journal.pone.0103702
|
| 68 |
Sobhi Gaba, Anjali Saini, Gurpreet Singh, Vikramdeep Monga. An insight into the medicinal attributes of berberine derivatives: A review. Bioorganic & Medicinal Chemistry 2021; 38: 116143 doi: 10.1016/j.bmc.2021.116143
|
| 69 |
Jie Wang, Tao Guo, Qi‐Sheng Peng, Shou‐Wei Yue, Shuang‐Xi Wang. Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice. Journal of Cellular and Molecular Medicine 2015; 19(11): 2607 doi: 10.1111/jcmm.12645
|
| 70 |
Binghui Li, Shiping Niu, Hongli Geng, Changkun Yang, Changliang Zhao. Berberine Attenuates Neonatal Sepsis in Mice By Inhibiting FOXA1 and NF-κB Signal Transduction Via the Induction of MiR-132-3p. Inflammation 2021; 44(6): 2395 doi: 10.1007/s10753-021-01510-2
|
| 71 |
Cristiana Caliceti, Paola Rizzo, Arrigo Francesco Giuseppe Cicero. Potential Benefits of Berberine in the Management of Perimenopausal Syndrome. Oxidative Medicine and Cellular Longevity 2015; 2015: 1 doi: 10.1155/2015/723093
|
| 72 |
Ling YAO, Ling-Ling WU, Qian LI, Qin-Mei HU, Shu-Yuan ZHANG, Kang LIU, Jian-Qin JIANG. Novel berberine derivatives: Design, synthesis, antimicrobial effects, and molecular docking studies. Chinese Journal of Natural Medicines 2018; 16(10): 774 doi: 10.1016/S1875-5364(18)30117-1
|